AzTrials
AzTrials

Arterial StiffnessNCT04510974

RAAS and Arterial Stiffness in SCI

An observational study of Arterial Stiffness and Renin Angiotensin Aldosterone System, run by James J. Peters Veterans Affairs Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study is examining differences in central arterial stiffness, orthostatic changes in blood pressure, norepinephrine, and plasma renin in individuals with spinal cord injury compared with age-matched uninjured controls. Read more about this study

Who is it for?
Ages 21 to 70 years
What is being tested?
Spinal Cord Injury
How many people
33 participants
Where
1 siteUnited States
Study dates
30 Jun 2018to 1 Dec 2020
Phase
Observational
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 70 years
  • All sexes
  • Adult, Older adult

Study population: Outpatient individuals with SCI, flyers in town

Who may be able to join

  • SCI participants:
  • injured between C1-T1 and T6-T12
  • wheelchair dependent
  • AIS classification A, B or C
  • Injured occurred more than 1 year ago

Who cannot join

  • currently have an illness or infection
  • current smoker of at least 1 year
  • controlled or uncontrolled hypertension or diabetes mellitus
  • Neurological condition other than SCI (Alzheimer's disease, dementia, stroke, multiple sclerosis, Parkinson's disease)
  • cardiovascular disease (coronary heart disease, congestive heart failure, peripheral artery disease)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • James J Peters VAMC

    The Bronx, New York, 10468

Other trials in United States

About this study

Official title: Orthostatic Blood Pressure and Arterial Stiffness in Persons With SCI: The Effect of RAAS System

The study is examining differences in central arterial stiffness, orthostatic changes in blood pressure, norepinephrine, and plasma renin in individuals with spinal cord injury compared with age-matched uninjured controls.

Read the detailed description

The study is examining differences in central arterial stiffness, orthostatic changes in blood pressure, norepinephrine, and plasma renin in individuals with spinal cord injury compared with age-matched uninjured controls. Arterial stiffness and blood pressure will be collected in the laying down position. A blood sample of norepinephrine and plasma renin will also be collected. The participant will tilt to 30, 45 and 60 degrees for 10 minutes at each angel. Blood pressure and heart rate will be monitored at each angle. Another blood sample of renin and norepinephrine will be collected at the end of 10 minutes at 60 degrees.

Being tested
Spinal Cord Injury
Medical subject headings
Hypotension, Orthostatic, Spinal Cord Injuries, Hypotension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Spinal Cord InjuryOther

    Spinal Cord Injury

Study groups in NCT04510974
Study groupRoleWhat they receive
Cervical SCIAges between 21-70 years old Injured between C1-T1 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago
Receives: Other: Spinal Cord Injury
Thoracic SCIAges between 21-70 Injured between T6-T12 Wheelchair dependent AIS classification of A, B or C Injury occurred more than 1 year ago
Receives: Other: Spinal Cord Injury
Able-bodied ControlAges between 21-70

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pulse Wave Velocity (m/s)

    Determine average pulse wave velocity among the three groups.

    Measured: 2 years

Secondary outcomes (3)
  1. Systolic Blood Pressure (mmHg)

    Determine differences in blood pressure among groups

    Measured: 2 years

  2. Plasma Renin (pg/ml)

    Determine differences in plasma renin among the groups

    Measured: 2 years

  3. Norepinephrine (pg/ml)

    Determine differences in plasma norepinephrine among the groups.

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2020
  2. Study start30 Jun 2018
  3. Primary completion1 Dec 2020
  4. Study completion1 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04510974
Sponsor's protocol ID
WEC-18-025
Status last verified
Feb 2025
First submitted
10 Aug 2020
Last updated
20 Feb 2025
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Arterial Stiffness and Renin Angiotensin Aldosterone System, run by James J. Peters Veterans Affairs Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 20 Feb 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pulse Wave Velocity (m/s) (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in